Neurim Pharmaceuticals Ltd.
17
0
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
11.8%
2 terminated/withdrawn out of 17 trials
86.7%
+0.2% vs industry average
35%
6 trials in Phase 3/4
46%
6 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
Role: lead
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
Role: lead
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Role: lead
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Role: lead
Efficacy and Safety of Slenyto for Insomnia in Children With ASD
Role: lead
Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients
Role: lead
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
Role: lead
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
Role: lead
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
Role: lead
Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Role: lead
Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients
Role: collaborator
Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients
Role: collaborator
Investigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult Subjects
Role: lead
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia
Role: lead
Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
Role: lead
A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
Role: lead
The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment
Role: collaborator
All 17 trials loaded